Seven Eight Capital, LP Tandem Diabetes Care Inc Transaction History

Seven Eight Capital, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$24.18 - $42.46 $1.25 Million - $2.2 Million	51,861 New	51,861 $1.27 Million
Q4 2021 Feb 14, 2022	SELL	$118.18 - $153.21 $1.6 Million - $2.07 Million	-13,514 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$93.51 - $129.4 $1.26 Million - $1.75 Million	13,514 New	13,514 $1.61 Million
Q2 2021 Aug 13, 2021	SELL	$77.0 - $100.19 $239,778 - $311,991	-3,114 Closed	0 $0
Q4 2020 Feb 09, 2021	SELL	$86.4 - $121.75 $689,990 - $972,295	-7,986 Reduced 71.95%	3,114 $298,000
Q3 2020 Nov 16, 2020	BUY	$95.43 - $116.09 $1.06 Million - $1.29 Million	11,100 New	11,100 $1.26 Million
Q2 2019 Aug 12, 2019	SELL	$54.41 - $71.7 $3.73 Million - $4.91 Million	-68,539 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$32.25 - $73.56 $2.21 Million - $5.04 Million	68,539 New	68,539 $4.35 Million

353

71.8M

3.36M

229K

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $2.26B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

Get notified when there are updates to the investment portfolio of Seven Eight Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Seven Eight Capital, LP with notifications on news.